Antibiotice Iasi Net Profit Spikes 114% YoY To RON8.6M In 1Q/2022
May 13, 2022
Antibiotice Iasi Net Profit Spikes 114% YoY To RON8.6M In 1Q/2022.
Antibiotice Iasi (ATB.RO), the biggest Romanian-held drug maker, reported a net profit net of RON8.6 million for the first three months of 2022, up 113.7% from the year-earlier period, in line with calculations by Ziarul Financiar (ZF) daily based on the company’s financial (...)
[Read the article in Ziarul Financiar]